NO20004896L - Pyridazinonhydrokloridforbindelse og fremgangsmÕte for fremstilling derav - Google Patents
Pyridazinonhydrokloridforbindelse og fremgangsmÕte for fremstilling deravInfo
- Publication number
- NO20004896L NO20004896L NO20004896A NO20004896A NO20004896L NO 20004896 L NO20004896 L NO 20004896L NO 20004896 A NO20004896 A NO 20004896A NO 20004896 A NO20004896 A NO 20004896A NO 20004896 L NO20004896 L NO 20004896L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- pyridazinone
- hydrochloride compound
- pyridazinone hydrochloride
- carbonylmethoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/22—Nitrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/12—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Det er beskrevet et 3/2-hydroklorid av 4-klor-5-[3-(4-benzylpiperazin-1- yl)karbonylmetoksy-4-metoksybenzylamino]-3(2H)-pyridazinon, og også en fremgangsmåte for fremstilling av 3/2-hydrokloridet av 4-klor-5-[3-(4- benzylpiperazin-1-yl)karbonylmetoksy-4-metoksybenzylamino]-3(2H)- pyridazinon som omfatter krystallisering i alkoholtypeoppløsningsmiddel eller et alkoholtype-estertypeblandet oppløsningsmiddel l nærvær av hydrogen- klorid og vann.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8592098 | 1998-03-31 | ||
PCT/JP1999/001629 WO1999050248A1 (en) | 1998-03-31 | 1999-03-30 | Pyridazinone hydrochloride compound and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20004896D0 NO20004896D0 (no) | 2000-09-29 |
NO20004896L true NO20004896L (no) | 2000-10-12 |
Family
ID=13872231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20004896A NO20004896L (no) | 1998-03-31 | 2000-09-29 | Pyridazinonhydrokloridforbindelse og fremgangsmÕte for fremstilling derav |
Country Status (14)
Country | Link |
---|---|
US (1) | US6310065B1 (no) |
EP (1) | EP1066265A1 (no) |
JP (1) | JP2002509919A (no) |
KR (1) | KR20010042078A (no) |
CN (1) | CN1293661A (no) |
AU (1) | AU742553B2 (no) |
CA (1) | CA2326506A1 (no) |
IL (1) | IL138521A0 (no) |
NO (1) | NO20004896L (no) |
NZ (1) | NZ506959A (no) |
SK (1) | SK14742000A3 (no) |
TW (1) | TW499425B (no) |
WO (1) | WO1999050248A1 (no) |
ZA (1) | ZA200004927B (no) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US7501426B2 (en) | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
DE102005035891A1 (de) | 2005-07-30 | 2007-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
NZ573360A (en) | 2006-05-04 | 2012-08-31 | Boehringer Ingelheim Int | Polymorphic forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine |
AR071175A1 (es) | 2008-04-03 | 2010-06-02 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante |
KR20190016601A (ko) | 2008-08-06 | 2019-02-18 | 베링거 인겔하임 인터내셔날 게엠베하 | 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료 |
UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
JP2012502081A (ja) | 2008-09-10 | 2012-01-26 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 糖尿病及び関連症状の治療のための組み合わせ治療 |
US8978895B2 (en) * | 2008-10-01 | 2015-03-17 | Rickey E. Wark | Self-cleaning coal separator grids with multiple cleaning combs |
US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
TWI508965B (zh) | 2008-12-23 | 2015-11-21 | Boehringer Ingelheim Int | 有機化合物的鹽形式 |
TW201036975A (en) | 2009-01-07 | 2010-10-16 | Boehringer Ingelheim Int | Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy |
JP2013512229A (ja) | 2009-11-27 | 2013-04-11 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 遺伝子型が同定された糖尿病患者のリナグリプチン等のddp−iv阻害薬による治療 |
NZ602921A (en) | 2010-05-05 | 2016-01-29 | Boehringer Ingelheim Int | Combination therapy comprising the administration of a glp-1 receptor agonist and a ddp-4 inhibitor |
MX2012014247A (es) | 2010-06-24 | 2013-01-18 | Boehringer Ingelheim Int | Terapia para la diabetes. |
US9034883B2 (en) | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
EP3517539B1 (en) | 2011-07-15 | 2022-12-14 | Boehringer Ingelheim International GmbH | Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes |
US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
WO2013171167A1 (en) | 2012-05-14 | 2013-11-21 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome |
WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
US9526728B2 (en) | 2014-02-28 | 2016-12-27 | Boehringer Ingelheim International Gmbh | Medical use of a DPP-4 inhibitor |
EP3468562A1 (en) | 2016-06-10 | 2019-04-17 | Boehringer Ingelheim International GmbH | Combinations of linagliptin and metformin |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3080131B2 (ja) * | 1993-06-29 | 2000-08-21 | 日産化学工業株式会社 | ピリダジノン誘導体 |
IL110040A (en) * | 1993-06-29 | 2000-07-16 | Nissan Chemical Ind Ltd | Pyridazinone derivatives their preparation and pharmaceutical compositions comprising them |
-
1999
- 1999-03-30 SK SK1474-2000A patent/SK14742000A3/sk unknown
- 1999-03-30 IL IL13852199A patent/IL138521A0/xx unknown
- 1999-03-30 WO PCT/JP1999/001629 patent/WO1999050248A1/en not_active Application Discontinuation
- 1999-03-30 JP JP2000541153A patent/JP2002509919A/ja not_active Withdrawn
- 1999-03-30 CN CN99804120A patent/CN1293661A/zh active Pending
- 1999-03-30 NZ NZ506959A patent/NZ506959A/en unknown
- 1999-03-30 TW TW088105033A patent/TW499425B/zh active
- 1999-03-30 AU AU29606/99A patent/AU742553B2/en not_active Ceased
- 1999-03-30 EP EP99910776A patent/EP1066265A1/en not_active Withdrawn
- 1999-03-30 KR KR1020007010430A patent/KR20010042078A/ko not_active Application Discontinuation
- 1999-03-30 CA CA002326506A patent/CA2326506A1/en not_active Abandoned
- 1999-03-30 US US09/646,127 patent/US6310065B1/en not_active Expired - Fee Related
-
2000
- 2000-09-15 ZA ZA200004927A patent/ZA200004927B/en unknown
- 2000-09-29 NO NO20004896A patent/NO20004896L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1999050248A1 (en) | 1999-10-07 |
SK14742000A3 (sk) | 2001-03-12 |
CA2326506A1 (en) | 1999-10-07 |
NZ506959A (en) | 2002-02-01 |
TW499425B (en) | 2002-08-21 |
AU2960699A (en) | 1999-10-18 |
AU742553B2 (en) | 2002-01-03 |
EP1066265A1 (en) | 2001-01-10 |
US6310065B1 (en) | 2001-10-30 |
NO20004896D0 (no) | 2000-09-29 |
KR20010042078A (ko) | 2001-05-25 |
ZA200004927B (en) | 2001-12-24 |
JP2002509919A (ja) | 2002-04-02 |
IL138521A0 (en) | 2001-10-31 |
CN1293661A (zh) | 2001-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20004896L (no) | Pyridazinonhydrokloridforbindelse og fremgangsmÕte for fremstilling derav | |
GR851039B (no) | ||
TW347387B (en) | Piperidine derivatives | |
AU563448B2 (en) | Substituted 4,5-dihydro-6-(substituted)-phenyl-3(2h)- pyridazinones and 6-(substituted)phenyl-3(2h)-pyridazinones | |
DK417185D0 (da) | 4,5-dihydro-3(2h)-pyridazinoner, fremgangsmaade til fremstilling derafog deres anvendelse | |
UA7140A1 (uk) | Спосіб отримання похідних піридіну | |
NO964813L (no) | Fremgangsmåte for stabilisering av duocarmycinderivater | |
AU8722991A (en) | Arylpyridazinones | |
DK0567271T3 (da) | Steroidderivater til behandling af prostatahypertrofi, fremgangsmåde til fremstilling heraf og anvendelser heraf | |
DK129282A (da) | Fremgangsmaade til fremstilling af indolylethylderivater | |
ATE34741T1 (de) | 6-(acylaminoaryl)-3(2h)-pyridazinonderivate, ihre herstellung und verwendung. | |
CA2226894A1 (en) | 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives | |
ES2004386A6 (es) | Un procedimiento para producir un nuevo derivado de difluorohalometoxifenilo | |
CA2129013A1 (en) | Pyridinecarboximidamide compounds and the use thereof | |
RU2000127101A (ru) | Производное пиридазинон гидрохлорида и способ его получения | |
TW327635B (en) | Process for making an epoxide | |
JPS539321A (en) | Agri-horticultural fungicide | |
NO20006183D0 (no) | Fremgangsmåte til fremstilling av et 3(2H)-pyridazinon-4- substituert amino-5-klorderivat | |
DK0788472T3 (da) | Fremgangsmåde til fremstilling af 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalenderivater | |
NO952913L (no) | Forbedret fremgangsmåte og sammensetning for delignifisering av et lignocellulosemateriale | |
PT869957E (pt) | Derivados de 3(2h)-piridazinona e composicoes farmaceuticas que contem estes compostos | |
GR3006342T3 (no) | ||
JPS54135785A (en) | Pyridazinone derivative and its preparation | |
IL152696A0 (en) | Process for the preparation of pesticidal compounds | |
EP1067119A4 (en) | PROCESS FOR ISOLATION OF N-PROTECTED S-PHENYLCYSTEINE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |